The Termeer Foundation
David Meeker currently serves as Chair, President, and CEO of Rhythm Pharmaceuticals, a position held since July 2020. Prior to this role, David Meeker was the CEO of KSQ Therapeutics, Inc. from September 2017 to July 2020. David Meeker also held the position of President and CEO at Genzyme from October 2011 to July 2017, showcasing extensive leadership experience in the pharmaceutical industry.
This person is not in the org chart
The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation is a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines.